Evidence map

ReviewClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026

CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy.

Nada Khairi Younis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41621014